<< Previous article
Do You Make These [S...
Next article > >
Setting your LIMS Pr...

SMi's 8th Annual Pharmaceutical Microbiology Conference

Pharmaceutical Microbiology

: 21 Jan 2019 - 22 Jan 2019

: London, United Kingdom

Sector: Laboratory Equipment, Pharmaceutical

Type: Conference, Exhibition, Workshop

Addressing the key challenges, trends and strategies in contamination control

SPONSORS: Mettler Toledo, Biomerieux and Copan Group

James Drinkwater, Chairman, Pharmaceutical & Healthcare Sciences Society
Olivier Chancel, Sterility and Aseptic Process Assurance, Expert, Boehringer Ingelheim
The pharmaceutical microbiology industry has seen many changes during the progression into the 21st century. With advances in rapid microbiological methods, revisions being made to regulations in the industry, enhanced knowledge of the human microbiome, and novel testing methods, this industry is ever expanding. In fact, the value of the rapid microbiology testing market is expected to reach USD 6.2 Billion by 2022, expanding at a CAGR of 7.3% from 2016 to 2022. This is the 8th year of a conference which is continually run by SMi and which has been very successful over the past few years.
Developing on last years’ success, Pharmaceutical Microbiology UK 2019 will bring together industry experts to discuss and analyze the latest advancement and challenges within pharmaceutical microbiology. Discover how you can keep up with regulatory changes, and maintain the utmost efficiency during production and testing.

Event Hashtag: #SMiPharmaMicro

At the 8th Annual Pharmaceutical Microbiology Conference, you will gain insight into:
  • Challenges in development of a contamination control strategy for different product types
  • A series of learning experiences within contamination from Boehringer Ingelheim
  • The use of vaporized hydrogen peroxide bio-decontamination technology in microbiology contamination control
  • Case studies in deinococcus and fungal and bacterial spores in cleanrooms
  • Influence of temperature of incubation on results of microbiological environmental monitoring
  • Risk mitigation strategies for animal-derived raw materials

  • Alexander Stoll, VP Competence Center Microbiology & Aseptic Technique Quality Management, Fresenius Kabi Di Morris, Senior Manager, Team Leader, Vaccines Quality Audit, GSK
  • Marine Marius, Scientist, Analytical Research & Development Europe, Sanofi Pasteur
  • Philippe Dutot, Sterility Assurance Specialist, Novo Nordisk
  • Renate Rosengarten, Professor and Chair of Bacteriology and Hygiene, University of Veterinary Medicine Vienna
  • Thierry Bonnevay, Microbiology Platform Head, Analytical Research and Development, Sanofi Pasteur
  • Tim Eaton, Sterile Manufacturing Specialist, AstraZeneca
  • Rapid Microbial Methods Revision of Annex 1 and impact on pharmaceutical microbiology
  • Contamination control strategies and case studies
  • Mycoplasma detection, prevention and control
  • Future of endotoxin testing in pharmaceutical industries
  • Strengths and weaknesses of vaporized Hydrogen peroxide as a bio-contamination control agent
  • Mold contamination control 
  • Influence of temperature of incubation on results of microbiological environmental monitoring
View the full agenda: www.pharma-microbiology.com
Senior Microbiologist, Lead Scientist, Laboratory Manager, QA Specialist Drug Substance External Manufacturer, Business Development Manager – Testing, Pharmaceutical Microbiology Consultant, Higher Pharmacopoeial Scientist, Analytical Standards Specialist

Copthorne Tara Hotel, Scarsdale Pl, Kensington
W8 5SY
United Kingdom


SMi Ltd.
Phone: +44 0 207 827 6186
Email: events@smi-online.co.uk
Visit: https://www.smi-online.co.uk/pharmaceuticals/

<< Previous article
Do You Make These [S...
Next article > >
Setting your LIMS Pr...